Welcome!

News Feed Item

Migraine Global Clinical Trials Review, H2, 2013

NEW YORK, Oct. 23, 2013 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:

Migraine Global Clinical Trials Review, H2, 2013
http://www.reportlinker.com/p0681715/Migraine-Global-Clinical-Trials-Review-H2-2013.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Therapy

Migraine Global Clinical Trials Review, H2, 2013

Summary

GlobalData's clinical trial report, "Migraine Global Clinical Trials Review, H2, 2013" provides data on the Migraine clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Migraine. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Migraine. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
- Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
- Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

- Understand the dynamics of a particular indication in a condensed manner
- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
- Obtain discontinued trial listing for trials across the globe
- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies
Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 5
Introduction 6
Migraine 6
Report Guidance 6

Clinical Trials by Region 7
Clinical Trials by Country 8
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Five Countries Contributing to Clinical Trials in Europe 11
Top Countries Contributing to Clinical Trials in North America 12
Top Countries Contributing to Clinical Trials in Middle East and Africa 13
Top Five Countries Contributing to Clinical Trials in Central and South America 14
Clinical Trials by BRIC Nations 15
Clinical Trials by G7 Nations 16
Clinical Trials in G7 Nations by Trial Status 17
Clinical Trials by E7 Nations 18
Clinical Trials in E7 Nations by Trial Status 19
Clinical Trials by Phase 20
In Progress Trials by Phase 21
Clinical Trials by Trial Status 22
Unaccomplished Trials of Migraine 23
Subjects Recruited Over a Period of Time 27
Prominent Sponsors 28
Top Companies Participating in Migraine Therapeutics Clinical Trials 30
Prominent Drug Comparison 32
Clinical Trial Profiles 33
Clinical Trial Overview of Top Companies 33

Merck & Co., Inc. 33
Clinical Trial Overview of Merck & Co., Inc. 33
GlaxoSmithKline plc 36
Clinical Trial Overview of GlaxoSmithKline plc 36
Johnson & Johnson 39
Clinical Trial Overview of Johnson & Johnson 39
Allergan, Inc. 42
Clinical Trial Overview of Allergan, Inc. 42
AstraZeneca PLC 44
Clinical Trial Overview of AstraZeneca PLC 44
Pfizer Inc. 46
Clinical Trial Overview of Pfizer Inc. 46
Banyan Group, Inc. 48
Clinical Trial Overview of Banyan Group, Inc. 48
NuPathe Inc. 49
Clinical Trial Overview of NuPathe Inc. 49
Endo Health Solutions Inc. 50
Clinical Trial Overview of Endo Health Solutions Inc. 50

Alexza Pharmaceuticals, Inc. 51
Clinical Trial Overview of Alexza Pharmaceuticals, Inc. 51
Clinical Trial Overview of Top Institutes / Government 52
Danish Headache Center 52
Clinical Trial Overview of Danish Headache Center 52
Thomas Jefferson University 54
Clinical Trial Overview of Thomas Jefferson University 54
Montefiore Medical Center 55
Clinical Trial Overview of Montefiore Medical Center 55
Johns Hopkins University 56
Clinical Trial Overview of Johns Hopkins University 56
The Cleveland Clinic 57
Clinical Trial Overview of The Cleveland Clinic 57
Chengdu University of Traditional Chinese Medicine 58
Clinical Trial Overview of Chengdu University of Traditional Chinese Medicine 58
University of Pittsburgh 59
Clinical Trial Overview of University of Pittsburgh 59
Glostrup University Hospital 60
Clinical Trial Overview of Glostrup University Hospital 60
Shahid Beheshti University 61
Clinical Trial Overview of Shahid Beheshti University 61
Swedish Medical Center 62
Clinical Trial Overview of Swedish Medical Center 62

Five Key Clinical Profiles 63
Appendix 109
Abbreviations 109
Definitions 109
Research Methodology 110
Secondary Research 110
About GlobalData 111
Contact Us 111
Disclaimer 111
Source 112


List of Tables
Migraine Therapeutics Market, Global, Clinical Trials by Zone, 2013* 7
Migraine Therapeutics Market, Global, Clinical Trials by Top Countries, 2013* 8
Migraine Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2013* 9
Migraine Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2013* 10
Migraine Therapeutics Clinical Trials, Europe, Top Five Countries, 2013* 11
Migraine Therapeutics Clinical Trials, North America, Top Countries, 2013* 12
Migraine Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2013* 13
Migraine Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2013* 14
Migraine Therapeutics Clinical Trials, BRIC Countries, 2013* 15
Migraine Therapeutics Clinical Trials, G7 Countries, 2013* 16
Migraine Therapeutics Market, G7 Countries, Clinical Trials by Trial Status, 2013* 17
Migraine Therapeutics Clinical Trials, E7 Countries, 2013* 18
Migraine Therapeutics Market, E7 Countries, Clinical Trials by Trial Status, 2013* 19
Migraine Therapeutics Market, Global, Clinical Trials by Phase, 2013* 20
Migraine Therapeutics Market, Global, Clinical Trials In Progress by Phase 2013* 21

Migraine Therapeutics Market, Global, Clinical Trials by Trial Status, 2013* 22
Migraine Therapeutics Market, Global, Suspended Clinical Trials, 2013* 23
Migraine Therapeutics Market, Global, Withdrawn Clinical Trials, 2013* 24
Migraine Therapeutics Market, Global, Terminated Clinical Trials, 2013* 25
Migraine Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2007-2012 27
Migraine Therapeutics Clinical Trials, Global, Key Sponsors, 2013* 29
Migraine Therapeutics Clinical Trials, Global, Top Companies by Phase, 2013* 31
Migraine Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2013* 32
Migraine Therapeutics Clinical Trials Market, Global, Clinical Trials by Merck & Co., Inc., 2013* 33
Migraine Therapeutics Clinical Trials Market, Global, Clinical Trials by GlaxoSmithKline plc, 2013* 36
Migraine Therapeutics Clinical Trials Market, Global, Clinical Trials by Johnson & Johnson, 2013* 39
Migraine Therapeutics Clinical Trials Market, Global, Clinical Trials by Allergan, Inc., 2013* 42
Migraine Therapeutics Clinical Trials Market, Global, Clinical Trials by AstraZeneca PLC, 2013* 44
Migraine Therapeutics Clinical Trials Market, Global, Clinical Trials by Pfizer Inc., 2013* 46
Migraine Therapeutics Clinical Trials Market, Global, Clinical Trials by Banyan Group, Inc., 2013* 48

Migraine Therapeutics Clinical Trials Market, Global, Clinical Trials by NuPathe Inc., 2013* 49
Migraine Therapeutics Clinical Trials Market, Global, Clinical Trials by Endo Health Solutions Inc., 2013* 50
Migraine Therapeutics Clinical Trials Market, Global, Clinical Trials by Alexza Pharmaceuticals, Inc., 2013* 51
Migraine Therapeutics Clinical Trials Market, Global, Clinical Trials by Danish Headache Center, 2013* 52
Migraine Therapeutics Clinical Trials Market, Global, Clinical Trials by Thomas Jefferson University, 2013* 54
Migraine Therapeutics Clinical Trials Market, Global, Clinical Trials by Montefiore Medical Center, 2013* 55
Migraine Therapeutics Clinical Trials Market, Global, Clinical Trials by Johns Hopkins University, 2013* 56
Migraine Therapeutics Clinical Trials Market, Global, Clinical Trials by The Cleveland Clinic, 2013* 57
Migraine Therapeutics Clinical Trials Market, Global, Clinical Trials by Chengdu University of Traditional Chinese Medicine, 2013* 58
Migraine Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Pittsburgh, 2013* 59
Migraine Therapeutics Clinical Trials Market, Global, Clinical Trials by Glostrup University Hospital, 2013* 60
Migraine Therapeutics Clinical Trials Market, Global, Clinical Trials by Shahid Beheshti University, 2013* 61
Migraine Therapeutics Clinical Trials Market, Global, Clinical Trials by Swedish Medical Center, 2013* 62

List of Figures
Migraine Therapeutics Market, Global, Clinical Trials by Zone (%), 2013* 7
Migraine Therapeutics Market, Global, Clinical Trials by Top Countries, 2013* 8
Migraine Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2013* 9
Migraine Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2013* 10
Migraine Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2013* 11
Migraine Therapeutics Clinical Trials, North America, Top Countries (%), 2013* 12
Migraine Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2013* 13
Migraine Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2013* 14
Migraine Therapeutics Clinical Trials, BRIC Countries (%), 2013* 15
Migraine Therapeutics Clinical Trials, G7 Countries (%), 2013* 16
Migraine Therapeutics Market, G7 Countries, Clinical Trials by Trial Status, 2013* 17
Migraine Therapeutics Clinical Trials, E7 Countries (%), 2013* 18
Migraine Therapeutics Market, E7 Countries, Clinical Trials by Trial Status, 2013* 19
Migraine Therapeutics Market, Global, Clinical Trials by Phase (%), 2013* 20
Migraine Therapeutics Market, Global, Clinical Trials In Progress by Phase, 2013* 21
Migraine Therapeutics Market, Global, Clinical Trials by Trial Status, 2013* 22
Migraine Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2007-2012 27
Migraine Therapeutics Clinical Trials, Global, Key Sponsors, 2013* 28
Migraine Therapeutics Clinical Trials, Global, Top Companies by Phase, 2013* 30
Migraine Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2013* 32
GlobalData Methodology 110

To order this report: Migraine Global Clinical Trials Review, H2, 2013
http://www.reportlinker.com/p0681715/Migraine-Global-Clinical-Trials-Review-H2-2013.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Therapy

__________________________
Contact Clare: [email protected]
US: (339)-368-6001

Intl: +1 339-368-6001

SOURCE Reportlinker

More Stories By PR Newswire

Copyright © 2007 PR Newswire. All rights reserved. Republication or redistribution of PRNewswire content is expressly prohibited without the prior written consent of PRNewswire. PRNewswire shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.

Latest Stories
SYS-CON Events announced today that ReadyTalk, a leading provider of online conferencing and webinar services, has been named Vendor Presentation Sponsor at the 19th International Cloud Expo, which will take place on November 1–3, 2016, at the Santa Clara Convention Center in Santa Clara, CA. ReadyTalk delivers audio and web conferencing services that inspire collaboration and enable the Future of Work for today’s increasingly digital and mobile workforce. By combining intuitive, innovative tec...
Major trends and emerging technologies – from virtual reality and IoT, to Big Data and algorithms – are helping organizations innovate in the digital era. However, to create real business value, IT must think beyond the ‘what’ of digital transformation to the ‘how’ to harness emerging trends, innovation and disruption. Architecture is the key that underpins and ties all these efforts together. In the digital age, it’s important to invest in architecture, extend the enterprise footprint to the cl...
Fifty billion connected devices and still no winning protocols standards. HTTP, WebSockets, MQTT, and CoAP seem to be leading in the IoT protocol race at the moment but many more protocols are getting introduced on a regular basis. Each protocol has its pros and cons depending on the nature of the communications. Does there really need to be only one protocol to rule them all? Of course not. In his session at @ThingsExpo, Chris Matthieu, co-founder and CTO of Octoblu, walk you through how Oct...
SYS-CON Events announced today that Secure Channels will exhibit at the 19th International Cloud Expo, which will take place on November 1–3, 2016, at the Santa Clara Convention Center in Santa Clara, CA. The bedrock of Secure Channels Technology is a uniquely modified and enhanced process based on superencipherment. Superencipherment is the process of encrypting an already encrypted message one or more times, either using the same or a different algorithm.
Vidyo, Inc., has joined the Alliance for Open Media. The Alliance for Open Media is a non-profit organization working to define and develop media technologies that address the need for an open standard for video compression and delivery over the web. As a member of the Alliance, Vidyo will collaborate with industry leaders in pursuit of an open and royalty-free AOMedia Video codec, AV1. Vidyo’s contributions to the organization will bring to bear its long history of expertise in codec technolo...
Traditional on-premises data centers have long been the domain of modern data platforms like Apache Hadoop, meaning companies who build their business on public cloud were challenged to run Big Data processing and analytics at scale. But recent advancements in Hadoop performance, security, and most importantly cloud-native integrations, are giving organizations the ability to truly gain value from all their data. In his session at 19th Cloud Expo, David Tishgart, Director of Product Marketing ...
SYS-CON Events announced today that Bsquare has been named “Silver Sponsor” of SYS-CON's @ThingsExpo, which will take place on November 1–3, 2016, at the Santa Clara Convention Center in Santa Clara, CA. For more than two decades, Bsquare has helped its customers extract business value from a broad array of physical assets by making them intelligent, connecting them, and using the data they generate to optimize business processes.
If you’re responsible for an application that depends on the data or functionality of various IoT endpoints – either sensors or devices – your brand reputation depends on the security, reliability, and compliance of its many integrated parts. If your application fails to deliver the expected business results, your customers and partners won't care if that failure stems from the code you developed or from a component that you integrated. What can you do to ensure that the endpoints work as expect...
In his keynote at 18th Cloud Expo, Andrew Keys, Co-Founder of ConsenSys Enterprise, provided an overview of the evolution of the Internet and the Database and the future of their combination – the Blockchain. Andrew Keys is Co-Founder of ConsenSys Enterprise. He comes to ConsenSys Enterprise with capital markets, technology and entrepreneurial experience. Previously, he worked for UBS investment bank in equities analysis. Later, he was responsible for the creation and distribution of life sett...
Digitization is driving a fundamental change in society that is transforming the way businesses work with their customers, their supply chains and their people. Digital transformation leverages DevOps best practices, such as Agile Parallel Development, Continuous Delivery and Agile Operations to capitalize on opportunities and create competitive differentiation in the application economy. However, information security has been notably absent from the DevOps movement. Speed doesn’t have to negat...
The Transparent Cloud-computing Consortium (abbreviation: T-Cloud Consortium) will conduct research activities into changes in the computing model as a result of collaboration between "device" and "cloud" and the creation of new value and markets through organic data processing High speed and high quality networks, and dramatic improvements in computer processing capabilities, have greatly changed the nature of applications and made the storing and processing of data on the network commonplace.
Your business relies on your applications and your employees to stay in business. Whether you develop apps or manage business critical apps that help fuel your business, what happens when users experience sluggish performance? You and all technical teams across the organization – application, network, operations, among others, as well as, those outside the organization, like ISPs and third-party providers – are called in to solve the problem.
Cognitive Computing is becoming the foundation for a new generation of solutions that have the potential to transform business. Unlike traditional approaches to building solutions, a cognitive computing approach allows the data to help determine the way applications are designed. This contrasts with conventional software development that begins with defining logic based on the current way a business operates. In her session at 18th Cloud Expo, Judith S. Hurwitz, President and CEO of Hurwitz & ...
The vision of a connected smart home is becoming reality with the application of integrated wireless technologies in devices and appliances. The use of standardized and TCP/IP networked wireless technologies in line-powered and battery operated sensors and controls has led to the adoption of radios in the 2.4GHz band, including Wi-Fi, BT/BLE and 802.15.4 applied ZigBee and Thread. This is driving the need for robust wireless coexistence for multiple radios to ensure throughput performance and th...
Enterprise IT has been in the era of Hybrid Cloud for some time now. But it seems most conversations about Hybrid are focused on integrating AWS, Microsoft Azure, or Google ECM into existing on-premises systems. Where is all the Private Cloud? What do technology providers need to do to make their offerings more compelling? How should enterprise IT executives and buyers define their focus, needs, and roadmap, and communicate that clearly to the providers?